Arab & Middle East News
(ARABNEWSWIRE.COM, September 08, 2017 ) According to the report, North America biomarkers market is expected to reach USD 16.72 billion by 2020 from USD 9.57 billion in 2015, growing at a CAGR of 11.80% during forecast period 2015-2020.
View Full Report @ http://www.marketdataforecast.com/market-reports/north-america-biomarkers-market-193/
Biomarkers are described as the biological molecules or genes assist in crucial clinical decisions and diagnosis of health conditions in patients. These are also known as molecular markers or signature molecules and used to analyze the pharmacologic responses, biological & pathological conditions. Biomarkers are found extensively in body fluids and tissues. Biomarkers are helpful in drug discovery & development processes and assessment of disease conditions.
Download Free Sample Report @ http://www.marketdataforecast.com/market-reports/north-america-biomarkers-market-193/request-sample
Growing number of cancer patients, rising adoption of advanced technologies (such as advanced high throughput technologies), increasing research to discover & develop the innovative biomarkers, and existence of huge number of pharmaceutical companies are driving the growth of biomarkers market in North America. In addition, growing funding from public & private organizations, presence of major market players, and increasing collaborations among the pharmaceutical companies are further propelling the growth of biomarkers market in North America. However, poor regulatory systems and reimbursement policies for the validation of biomarkers tests are restraining the growth of biomarkers market in North America.
Avail Discount @ http://www.marketdataforecast.com/market-reports/north-america-biomarkers-market-193/request-discount
North America biomarkers market is segmented based on the product, type, application, and disease indications. Based on product, the market is further sub-segmented as consumables, software, and services. Based on type, the market is segmented as safety biomarkers, efficacy biomarkers, and validation biomarkers. Biomarkers application is further segmented as diagnostics developments, drug discovery & developments, personalized medicine, and disease risk assessment. Based on disease indications, the market is segmented as cancer, cardiovascular, neurological, and immunological disorders.
On the basis of geographical areas, North America biomarkers market is segmented as U.S., and Canada.
Buy now @ https://www.marketdataforecast.com/cart/buy-now/north-america-biomarkers-market-193
The key players in biomarkers market include, Bio-Rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Enzo Biochem (U.S.), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), EKF Diagnostics Holdings plc. (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France), and Signosis, Inc. (U.S.).
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast